Immune Checkpoint Blockade (ICB) has reshaped cancer care and can deliver durable remission in malignancies such as melanoma and non-small cell lung cancer.

The global next-generation sequencing (NGS) market is projected to grow from $14.94b in 2025 to $29.53b by 2030.

Cancer cachexia upregulates one-carbon metabolism in multiple organs throughout the body, a new mouse study reveals, ...